NCT06709261已完成不适用
EDS-2022-01: Safety and Performance of the OTTAVA™ Robotic System: A Prospective, Multi-Center Evaluation (FORTE)
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 32
- 试验地点
- 6
- 主要终点
- Procedure completion without conversion to open surgery
研究概览
简要总结
This study assesses safety and performance of the OTTAVA Robotic System, through 30 days postoperative, in subjects undergoing robotic-assisted Roux-en-Y Gastric Bypass (RYGB) procedure.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Criteria for Inclusion:
- •Willing and able to provide informed consent;
- •Scheduled for an elective primary RYGB surgical procedure;
- •American Society of Anesthesiologists classification ≤ ASA III;
- •Body habitus such that the procedure can be safely completed with OTTAVA Robotic System;
- •Body weight <500 lb (227 kg);
- •Patient presenting with class 2 or 3 obesity (BMI ≥ 35), regardless of comorbidities, or obesity with health risk satisfying 2022 ASMBS/IFSO indications for bariatric surgery; and
- •A minimum of 21 years of age (at time of consent).
- •Criteria for
排除标准
- •Surgeon determination that there is a medical condition, that makes surgery too risky, including intraoperative finding;
- •Concomitant surgical procedure including cholecystectomy (hiatal hernia repair up to 5 cm and adhesiolysis allowed);
- •Upper abdominal surgery within two years prior to enrollment (prior laparoscopic cholecystectomy allowed);
- •Evidence of hiatal hernia >5 cm (preoperative/intraoperative);
- •Enrolled in another investigational study that may confound the results of this study;
- •Emergency surgery;
- •Active pregnancy; or
- •Subject from a vulnerable population, including anyone unable to adequately provide informed consent.
研究组 & 干预措施
OTTAVA Robotic System
Experimental
Procedure with the OTTAVA Robotic System
干预措施: OTTAVA Robotic System (Device)
结局指标
主要结局
Procedure completion without conversion to open surgery
时间窗: Procedure day
Occurrence of intraoperative and postoperative device- or procedure-related complications
时间窗: Through 30 days post-procedure
次要结局
- Occurrence of all adverse events(Through 30 days post-procedure)
- Total operative time(Procedure day)
- Estimated blood loss(Procedure day)
- Occurrence of blood transfusion(Procedure day)
- Device malfunction details(Procedure day)
- Length of hospital stay(Hospital stay, assessed up to 30 days)
- Hospital readmission(Through 30 days)
- Reoperation(Through 30 days)
- Anastomotic leak(Through 30 days)
- Anastomotic stricture(Through 30 days)
- Mortality(Through 30 days)
研究者
研究点 (6)
Loading locations...
相似试验
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06762340[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT04945941[Redacted]
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06733259[Redacted]
已完成
不适用
Clinical Investigation (Beta) of a New Developed Prosthetic KneeNCT06748729Össur Iceland ehf11
Withheld
不适用
[Trial of device that is not approved or cleared by the U.S. FDA]NCT06422065[Redacted]